{"url_path":"/sec/cosm/8-k/2026-07-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 FINANCIAL STATEMENTS AND EXHIBITS.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1474167/0001477932-26-004357-index.html","accession_number":"0001477932-26-004357","cik":"0001474167","ticker":"COSM","issuer_name":"Cosmos Health Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1474167/0001477932-26-004357-index.html","primary_entity_key":"0001474167","primary_entity_name":"Cosmos Health Inc."},"word_count":85,"has_tables":true,"body_markdown":"**ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.**\n\n \n\n(d) Exhibits.\n\n \n\nExhibit No.\n\n \n\nDescription\n\n[3.1](cosm_ex31.htm)\n\n \n\n[Certificate of Designation of Series B Preferred Stock, dated July 16, 2026.](cosm_ex31.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n \n\n3\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n**COSMOS HEALTH INC.**\n\n \n\n \n\n \n\n \n\nDate: July 16, 2026\n\nBy:\n\n*/s/ Georgios Terzis*\n\nGeorgios Terzis\n\n \n\nChief Financial Officer\n\n \n\n \n\n \n\n4"}